Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines

International Journal of Cancer

Volumn 75, Issue 5, 1998, Pages 706-712

  Scott, Prudence A E ^a   Gleadle, Jonathan M ^a   Bicknell, Roy ^a   Harris, Adrian L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MUTANT PROTEIN; RAS PROTEIN; SEX HORMONE; VASCULOTROPIN; VITAMIN D;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL HYPOXIA; CELL PH; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOGLYCEMIA; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

ANOXIA; BREAST NEOPLASMS; CALCITRIOL; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOKINES; NUCLEAR PROTEINS; PROGESTERONE; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032473399     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980302)75:5<706::AID-IJC8>3.0.CO;2-2     Document Type: Article

References (34)

1. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A. and STRUHL, K., Current protocols in molecular biology. J. Wiley, New York (1987).
2. BERKMAN, R.A., MERRILL, M.J., REINHOLD, W.C., MONACCI, W.T., SAXENA, A., CLARK, W.C., ROBERTSON, J.T., ALI, I.U. and OLDFIELD, E.H., Expression of the vascular permeability factor/vascular endothelial growth factor gene in the central nervous system neoplasms. J. clin. Invest., 91, 153-159 (1993).
3. BOOCOCK, C.A., CHARNOCK JONES, D.S., SHARKEY, A.M., MCLAREN, J., BARKER, P.J., WRIGHT, K.A., TWENTYMAN, P.R. and SMITH, S.K., Expression of vascular endothelial growth-factor and its receptors fit and kdr in ovarian-carcinoma. J. nat. Cancer Inst., 87, 506-516 (1995).
4. CHARNOCK, J.D., SHARKEY, A.M., RAJPUT, W.J., BURCH, D., SCHOFIELD, J.P., FOUNTAIN, S.A., BOOCOCK, C.A. and SMITH, S.K., Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod., 48, 1120-1128 (1993).
5. CULLINAN, B.K. and KOOS, R.D., Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology, 133, 829-837 (1993).
6. EBERT, B.L., FIRTH, J.D. and RATCLIFFE, P.J., Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences. J. biol. Chem., 270, 29083-29089 (1995).
7. FENTIMAN, I.S. and GREGORY, W.M., Perioperative hormones and prognosis in breast cancer. Europ. J. Cancer, 30A, 1892-1894 (1994).
8. FERNANDEZ, P. and SAFE, S., Growth inhibitory and antimitogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in T47D human breast cancer cells. Toxicol. Lett., 61, 185-197 (1992).
9. FERRARA, N., HOUCK, K., JAKEMAN, L. and LEUNG, D.W., Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol. Rev., 13, 18-32 (1992).
10. FIRTH, J.D., EBERT, B.L., PUGH, C.W. and RATCLIFFE, P.J., Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoeitin 3′ enhancer. Proc. nat. Acad. Sci. (Wash.), 91, 6496-6500 (1994).
11. FOLKMAN, J., What is the evidence that tumors are angiogenesis dependent? J. nat. Cancer Inst., 80, 4-6 (1990).
12. FOX, S., LEEK, R., SMITH, K., HOLLYER, J., GREENALL, M. and HARRIS, A., Tumor angiogenesis in node negative breast carcinomas-relationship to epidermal growth factor receptor and survival. Breast Cancer Res. Treat., 29, 109-116 (1994).
13. GAGLIARDI, A. and COLLINS, D.C., Inhibition of angiogenesis by antiestrogens. Cancer Res., 53, 533-535 (1993).
14. GLEADLE, J.M., EBERT, B.L., FIRTH, J.D. and RATCLIFFE, P.J., Regulation of angiogenic growth-factor expression by hypoxia, transition-metals, and chelating-agents. Amer. J. Physiol. Cell Physiol., 37, 1362-1368 (1995).
15. GOLDBERG, M.A. and SCHNEIDER, T.J., Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth-factor and erythropoietin. J. biol. Chem., 269, 4355-4359 (1994).
16. HARADA, S., NAGY, J.A., SULLIVAN, K.A., THOMAS, K.A., ENDO, N., RODAN, G.A. and RODAN, S.B., Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J. clin. Invest., 93, 2490-2496 (1994).
17. HLATKY, L., TSIONOU, C., HAHNFELDT, P. and COLEMAN, C.N., Mammary fibroblasts may influence breast-tumor angiogenesis via hypoxia-induced vascular endothelial growth-factor up-regulation and protein expression. Cancer Res., 54, 6083-6086 (1994).
18. HORAK, E., LEEK, R., KLENK, N., LEJEUNE, S., SMITH, K., STUART, N., STEPNIEWSKA, K. and HARRIS, A.L., Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastasis and survival in breast cancer. Lancet, 340, 1120-1124 (1992).
19. HOUCK, K.A., FERRARA, N., WINER, J., CACHIANES, G., LI, B. and LEUNG, D.W., The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol., 5, 1806-1814 (1991).
20. KIM, K.J., LI, B., WISER, J., ARMANINI, M., GILLETT, N., PHILLIPS, H.S. and FERRARA, N., Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362, 841-844 (1993).
21. KOOS, R.D., Increased expression of vascular endothelial growth permeability factor in the rat ovary following an ovulatory gonadotropin stimulus - potential roles in follicle rupture. Biol. Reprod., 52, 1426-1435 (1995).
22. MILLAUER, B., SHAWVER, L.K., PLATE, K.H., RISAU, W. and ULLRICH, A., Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367, 576-579 (1994).
23. MUKHOPADHYAY, D., TSIOKAS, L., ZHOU, X.-M., FOSTER, D., BRUGGE, J.S. and SUKHATME, V.P., Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375, 577-581 (1995).
24. OIKAWA, T., HIROTANI, K., OGASAWARA, H., KATAYAMA, T., NAKAMURA, O., IWAGUCHI, T. and HIRAGUN, A., Inhibition of angiogenesis by vitamin D3 analogues. Europ. J. Pharmacol., 178, 247-250 (1990).
25. PUGH, C.W., EBERT, B.L., EBRAHIM, O. and RATCLIFFE, P.J., Characterisation of functional domains within the mouse erythropoietin 3′ enhancer conveying oxygen-regulated responses in different cell lines. Biochim. biophys. Acta, 1217, 297-306 (1994).
26. RAK, J., MITSUHASHI, Y., BAYKO, L., FILMUS, J., SHIRASAWA, S., SASAZUKI, T. and KERBEL, R.S., Mutant ras oncogenes up-regulate VEGF/VPF expression - implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55, 4575-4580 (1995).
27. RAVINDRANATH, N., LITTLE, I.L., PHILLIPS, H.S., FERRARA, N. and ZELEZNIK, A.J., Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology, 131, 254-260 (1992).
28. SACKS, P.M., SMITH, K., NORMAN, A.P., GREENALL, M., LEJEUNE, S. and HARRIS, A.L., Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary node status. Europ. J. Cancer, 29A, 426-428 (1993).
29. SHWEIKI, D., ITIN, A., NEUFELD, G., GITAY, G.H. and KESHET, E., Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. clin. Invest., 91, 2235-2243 (1993).
30. SHWEIKI, D., ITIN, A., SOFFER, D. and KESHET, E., Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359, 843-845 (1992).
31. SHWEIKI, D., NEEMAN, M., ITIN, A. and KESHET, E., Induction of vascular endothelial growth-factor expression by hypoxia and by glucose deficiency in multicell spheroids - implications for tumor angiogenesis. Proc. nat. Acad. Sci. (Wash.), 92, 768-772 (1995).
32. WEIDNER, N., FOLKMAN, J., POZZA, F., BEVILACQUA, P., ALLRED, E.A., MOORE, H., MELI, S. and GASPARINI, G., Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. nat. Cancer Inst., 84, 1875-1887 (1992).
33. WOESSNER, R.D., MATTERN, M.R., MIRABELLI, C.K., JOHNSON, R.K. and DRAKE, F.H., Proliferation and cell-cycle dependent differences in expression of the 170kDa and 180kDa forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differentiation, 2, 209-214 (1991).
34. YAN, Z.P., WEICH, H.A., BERNART, W., BRECKWOLDT, M. and NEULEN, J., Vascular endothelial growth-factor (VEGF) messenger-ribonucleic-acid (messenger-RNA) expression in luteinized human granulosa-cells in-vitro. J. clin. Endocrinol. Metab., 77, 1723-1725 (1993).